Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 27 for “"Niosome"”.
-
Topical delivery of niacinamide, encapsulated in niosome and proniosome carriers
… Bouwstra, 2008:206). These systems are known as niosomes and proniosomes and the difference between them is the method of preparation (Seleci et al., 2016:4). Proniosomes are prepared to form a dry powder in order to have a longer storage life than the niosomes (Yeom et al., 2014:83), …
-
Topical delivery of artemether, encapsulated in niosome and proniosome carriers
… deliverance of drugs to the targeted sites. Niosomes are non-lipoidal biocarriers consisting of non-ionic surfactants and lipids, therefore these vesicles can encapsulate both lipophilic and hydrophilic drugs. Using niosomes during topical delivery has many advantages, i.e. 1) controlled …
-
Development and Evaluation of a Niosome Carrier for Topical Use of Antioxidant
… the similar bilayer structure to liposomes are niosomes. Theses carriers are widely used topically. Objective: The aim of this project was to design a niosome carrier system to deliver the antioxidant into the skin so that it exhibits the antioxidant effect. The drug candidates are two compounds …
-
Synthesis and Characterization of Potential Drug Delivery Systems using Nonionic Surfactant “Niosome”
Niosomes are synthetic microscopic vesicles consisting of an aqueous core enclosed in a bilayer consisting of cholesterol and one or more nonionic surfactants. They are made of biocompatible, biodegradable, non-toxic, non-immunogenic and non-carcinogenic agents which form closed spherical …
-
DEVELOPMENT AND CHARACTERIZATION OF NIOSOME-ENCAPSULATED DOCETAXEL FOR THE TREATMENT OF BREAST CANCER: IN-VITRO AND IN-VIVO EVALUATIONS
… due to low solubility and severe side effects. Niosomes offer an extended drug half-life, high versatility, and good biocompatibility, making them suitable carriers for drug delivery systems. The objective of the present research is to develop DTX-loaded niosomes to improve the therapeutic index …
-
The Characterization of Non-Ionic Surfactant Vesicles: A Release Rate Study for Drug Delivery
… We have proposed a model that incorporates a niosome, which is a non-ionic surfactant vesicle, within a biodegradable polymer hydrogel. The drug is encapsulated in the niosome, and the niosome is embedded within a three-dimensional hydrogel network. It is therefore critical that the release …
-
PEGylation of Niosomes
… organ of action. The drug is delivered using a niosome, a vesicle with an aqueous core and a bilayer membrane composed of non-ionic surfactants and cholesterol. Antibodies that recognize specific cell antigens are attached to the niosome to complete the targeting molecule, an immuno-niosome …
-
Non-ionic surfactant technology for the delivery and administration of sub-unit flu antigens
… IgA and other mucosal responses. Therefore, niosomes have been considered within this thesis to enhance the protection and delivery of sub-unit vaccines via the oral route and intramuscularly. Initial work included using Design of Experiments to optimise niosome/ bilosome vesicles prepared …
-
Application Of Supercritical Carbon Dioxide In Lipid Vesicle Design And Extraction Of Oil From Potato Chips
… of nonionic surfactant based lipid vesicle (niosome) production coupling a gas ejector with the rapid expansion of a supercritical solution was studied. Niosomes were prepared using Tween61, which was shown to be 4-6% soluble (wt. basis) in SC-CO2 ranging from 40 to 60°C and 10 to 20 MPa, and …
-
Dermal delivery of Centella asiatica using hyaluronic acid niosomal system for wound healing
… a biocompatible hydrogel with drug-loaded niosomes will allow easy application, and the beneficial effects of the hydrogel will also enhance healing. Objective: The aim of this project was to develop a niosome loaded hydrogel system to deliver bioactive compounds to skin wounds to …
-
Oral Delivery of Neuropeptide(s) to The Brain Utilizing a Ligand Niosomal Delivery System for The Treatment of Neurodegenerative Disorders
… and deliver the drugs directly to the brain. Niosomes were chosen as the preferred vesicle of choice as they are biocompatible and able to entrap both hydrophilic and lipophilic drugs. Notably, niosomes are also able to incorporate ligands into its structure to improve both the efficacy of …
-
Investigation of the stabilising effects of niosomes on the amorphous forms of roxithromycin
… the effect of the excipients used in the typical niosome preparation on the solid-state nature of three solid-state forms of roxithromycin. The second aim was to ascertain which niosome had the highest concentration of roxithromycin delivered topically to the target-site, the epidermis-dermis (ED) …
-
Antibody Targeting of Non Ionic Surfactant Vesicles to Vascular Inflammation
… conjugated to a non ionic surfactant vesicle (niosome) drug carrier. The IM7 conjugated immunoniosome has been shown to bind to endothelial and synovial lining cells in vitro. The preliminary research is involved with the development of the drug delivery vesicle, and the antibody linkage …
-
Rationally Reconstructed and Attenuated Vaccines for Epidemic Response
… delivery of the vaccine to sows, biodegradable niosome formulation composed of edible lipid, cholesterol, and charge stabilizer was optimized. The antigen loading capacity of the niosome was over 80% with minimal cellular cytotoxicity. In summary, the methods described in this thesis have …
-
Topical delivery of clofazimine, artemisone and decoquinate utilizing vesicles as carrier system
… delivery, though for this study liposomes, niosomes and transferosomes were selected. Dispersions containing a single API, a combination of all three APIs, as well as no API, were prepared for all three types of vesicles. Characterisation of dispersions containing 0.2%, 0.4% and 1% API was …
-
Topical delivery of clofazimine, artemisone and decoquinate utilizing vesicles as carrier system
… delivery, though for this study liposomes, niosomes and transferosomes were selected. Dispersions containing a single API, a combination of all three APIs, as well as no API, were prepared for all three types of vesicles. Characterisation of dispersions containing 0.2%, 0.4% and 1% API was …
-
Novel Encapsulation of Oxidizer Applied to Galvanic Cells: Aluminum / H2O2 Galvanic Cell as a Case Study
… utilizing a non-ionic surfactant vesicle (i.e. niosome). Once encapsulated, a second control element over the cathodic reactant is provided. The use of a polymer will be implemented to achieve stability and render further control over the encapsulated H2O2 solution. Implementation of the …
-
Dermal And Cellular Delivery Of An Endogenous Anti-ageing Peptide Using Niosomes
… hypothesized that a cationic charge within the niosomes would increase both cellular and trans-epidermal delivery. The specific objectives were to; (1) evaluate the key physicochemical properties of GHK-Cu for the eventual development of formulations for dermal delivery of this peptide, (2) …
-
The physico-chemical and biological analysis of microbial biosurfactants (BSs) for applications towards cancer therapies, wound healing dressings and drug delivery
… as well as the formulation of free BSs and niosomes encapsulating BSs incorporated into lyophilised composite polymeric wound dressings for potential chronic wound healings. The physico-chemical characteristics of four selected BSs 95Dd rhamnolipids (BS1a), 95/90 rhamnolipids (BS1b), …
-
Smart Packaging: A Novel Technique For Localized Drug Delivery For Ovarian Cancer
… system comprising non-ionic surfactant vesicles (niosomes) packaged within a temperature-sensitive chitosan network. This smart packaging, or package-within-a package system, provides two distinct advantages. First, the gel prevents circulation of the niosomes and maintains delivery in the …
Page 1 of 2